VC firm
Noro-Moseley Partners
Also known as Noro Moseley Partners IX B, Noro Moseley Partners SBIC, Noro-Moseley Partners IX-B, L.P., Noro-Moseley Partners SBIC, L.P.
- Investor type
- VC
- Investing status
- Activeas of 2026-09-17Source (opens in a new tab)
- Headquarters
- ATLANTA, GA, United States
- Founded
- 1983
- Assets under management
- $473MForm ADV private fund GAV, as of 2026-03-30Source (opens in a new tab)
- Funds
- 5
- Check size
- $5-20mSource (opens in a new tab)
- Legal name
- Noro-Moseley Partners, L.P.
Record updated 29 September 2026
About
Early growth equity for rapidly-scaling B2B technology and healthcare companies
Investment approach
- Thesis
- Since 1983, NMP has built deep domain expertise and curated a valuable network within the B2B technology and healthcare markets.Source (opens in a new tab)
- Takes board seats
- Yes
- Board policy
- Active Board Member
- Eligibility
- Year-over-year growth 50%+ Compelling unit economics Target revenue run rate $2M-20M SIGNIFICANT OPPORTUNITY FOR MARKET DISRUPTION Minimal prior funding <$20M
- Traction requirement
- Year-over-year growth 50%+
- Investing status notes
- We are actively investing in businesses that meet these key criteria
Funds
- Noro-Moseley Partners IX-B, L.P.
- Vintage 2023Main fund
- Noro-Moseley Partners SBIC, L.P.
- $3.7MVintage 2013, Main fund, SEC amount sold
- NORO-MOSELEY PARTNERS VIII, LP
- Main fund
- NORO MOSELEY PARTNERS VII, LP
- Main fund
- NORO-MOSELEY PARTNERS IX, LP
- Main fund
SEC registration
- Registered adviser
- NMP MANAGEMENT CORPORATION
- CRD number
- 162877 (opens in a new tab)
- SEC file number
- 802-107246
- Registration
- Exempt reporting adviser
- Regulatory AUM
- $473Mas of 2026-03-30
- Private funds reported
- 4
- Principal office
- ATLANTA, GA, United States
- SEC CIK
- 1585815, 1981387